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INTRODUCTION 
Exercise-induced muscle damage (EIMD) results in
transient muscle inflammation, strength loss, muscle
soreness (1) and can result in subsequent exercise
avoidance. This affects athletes, those who engage in
vigorous physical activity (2) and elderly people who
demonstrate chronic basal inflammation (3). Omega-3
(n-3) supplementation has been proposed to minimise
EIMD via its anti-inflammatory properties (4), however
its action remains unclear.
We aimed to examine the effects of n-3
supplementation on exercise-induced inflammatory
response following muscle-damaging exercise,
hypothesising a) n-3 supplementation would decrease
muscle inflammation and b) improve muscle function
measurements.
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CONCLUSION
In this study, even though we recorded some reduction in the plasma markers for the N-3 group, there was no
statistically significant decrease to allow us to draw any definitive conclusions about the n-3 supplementation on
exercise-induced muscle inflammation. However, there was a significant reduction in serum CK activity in N-3 group
whereby n-3 supplementation may potentially reduce muscle damage following EIMD. Additionally, there was no
impact on muscle function nor power output. Future studies might compare the dosage and duration of n-3
supplementation on muscle function or examine the effect of n-3 supplementation on EIMD during ageing-associated
muscle function loss, where increased basal inflammation is seen.
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14 physically active, healthy 
Caucasian males 
age, 25.07 ± 4.05 years
weight, 73.04 ± 9.82 kg
height, 1.79 ± 0.10 m
body fat, 10.7 ± 4.06 %
V̇O2max 62.42 ± 11.76 ml/kg-1/min-1
SUP, n = 7
3g/day of N-3
PLA, n = 7
placebo capsules
METHODS
4 
weeks
Downhill running    
(60 minutes 
at 65% V̇O2max
-10% gradient)
PRE EIMD
POST EIMD
Follow up assessments 
24h 48h 72h POST EIMD
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Figure 1. PLA group showed a larger increase in
plasma IL-6 compared to N-3 group immediately post-
EIMD (143.9% vs 131.1%, respectively), however, there
was no significant difference between groups at any
time point (p > 0.05). Data are presented as median
and interquartile range
Figure 2. No significant differences in median TNF-α
concentration were found between groups at any time
point (p > 0.05). However, TNF-α showed a smaller
increase for the N-3 group compared to the PLA during
the recovery phase at 24, 48 and 72 h post-EIMD. Data
are presented as median and interquartile range
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Figure 3. There was a significant difference in serum
CK activity between groups at 24 h post-EIMD (p =
0.048), with PLA showing a larger increase in serum CK
(baseline- vs 24 h post-EIMD) compared to N-3
(677.4% vs 459.6%, respectively). Data are presented
as median and interquartile range
Figure 4. No significant difference in VAS score
percentage change was observed between groups at
any time point (p > 0.05), with a peak in DOMS that was
similar in both groups. Data are presented as median
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Figure 5. A significant main effect for time was
observed for MVIC leg strength F5,6 = 7.45, p = 0.015,
η2p = 0.86, with both groups showing a significant
reduction in leg strength immediately post-EIMD.
However, there were no significant differences between
groups (p = 0.26) nor any group by time interactions (p
= 0.90). Data are presented as mean SD
Figure 6. A significant main effect for time was
observed for peak power F4,6 = 7.95, p = 0.014, η2p =
0.84, with PLA showing a larger reduction in peak
power at 24 h post-EIMD (pre- vs 24 h post-EIMD)
compared to the N-3 group (>96.6% vs N-3). However,
there were no significant differences between groups (p
= 0.31) nor any group by time interactions (p = 0.51).
Data are presented as mean
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